Comprehensive benchmarking of methods for mutation calling in circulating tumor DNA
Open Access
- 18 December 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Detection of somatic mutations in cell-free DNA (cfDNA) is challenging due to low variant allele frequencies and extensive DNA degradation. Here we develop a benchmarking strategy using longitudinal patient-matched cfDNA samples from individuals with colorectal and breast cancer. Samples with high and ultra-low levels of tumor-derived DNA are combined into controlled dilution series that preserve the properties of authentic cell-free DNA, including each patient’s germline and blood-cell mutation backgrounds. Using deep whole-genome (150x) and exome (2,000x) sequencing, we define a reference set of ~37,000 single nucleotide variants and ~58,000 indels to benchmark nine somatic variant callers across varying ctDNA levels and sequencing depths. We also explore machine learning–based tuning of individual callers and identify features that improve accuracy in cfDNA. This benchmarking resource clarifies the detection limits of current approaches and provides practical guidance for selecting somatic variant calling methods in liquid biopsy applications.Keywords
All Related Versions
Funding Information
- Ministry of Health -Singapore (OFIRG21nov-0083)
This publication has 49 references indexed in Scilit:
- Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective studyBritish Journal of Cancer, 2021
- Precision oncologyNature, 2020
- Precision oncology in the age of integrative genomicsNature Biotechnology, 2018
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumorsNature Communications, 2017
- Origins, structures, and functions of circulating DNA in oncologyCancer and Metastasis Reviews, 2016
- Characterization of the cell-free DNA released by cultured cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencingNature Communications, 2015
- Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detectionNature Methods, 2015
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011